title: Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase.
abstract: Aldehyde oxidase (AOX) is a cytosolic enzyme expressed across a wide range of species, including guinea pig and rhesus monkey. These species are believed to be the best preclinical models for studying human AOX-mediated metabolism. We compared AOX activity in rhesus monkeys, guinea pigs, and humans using phthalazine and N-[2-(dimethylamino)ethyl]acridone-4-carboxamide (DACA) as substrates and raloxifene as an inhibitor. Michaelis-Menten kinetics was observed for phthalazine oxidation in rhesus monkey, guinea pig, and human liver cytosol, whereas substrate inhibition was seen with DACA oxidase activity in all three livers. Raloxifene inhibited phthalazine and DACA oxidase activity uncompetitively in guinea pig, whereas mixed-mode inhibition was seen in rhesus monkey. Our analysis of the primary sequence alignment of rhesus monkey, guinea pig, and human aldehyde oxidase isoform 1 (AOX1) along with homology modeling has led to the identification of several amino acid residue differences within the active site and substrate entrance channel of AOX1. We speculate that some of these residues might be responsible for the differences observed in activity. Overall, our data indicate that rhesus monkeys and guinea pigs would overestimate intrinsic clearance in humans and would be unsuitable to use as animal models. Our study also showed that AOX metabolism in species is substrate-dependent and no single animal model can be reliably used to predict every drug response in humans.
authors.affiliation: Department of Chemistry, Washington State University, Pullman, Washington.
authors.forename: Kanika V
authors.initials: KV
authors.lastname: Choughule
authors.forename: John T
authors.initials: JT
authors.lastname: Barr
authors.forename: Jeffrey P
authors.initials: JP
authors.lastname: Jones
mesh_terms: D042931:Aldehyde Oxidase / Q000378:metabolism*; D000818:Animals; D003600:Cytosol / Q000201:enzymology* / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000201:enzymology* / Q000378:metabolism*; D008253:Macaca mulatta / Q000378:metabolism; D008297:Male; D010084:Oxidation-Reduction; D010793:Phthalazines / Q000378:metabolism
chemical_list: D010793:Phthalazines; C043388:phthalazine; D042931:Aldehyde Oxidase
references.citation: Eur J Cancer. 2002 May;38(8):1072-80
references.pmid: 12008195
references.citation: J Med Chem. 2010 Dec 23;53(24):8441-60
references.pmid: 20853847
references.citation: Drug Metab Dispos. 2012 Mar;40(3):625-34
references.pmid: 22190693
references.citation: Drug Metab Dispos. 2011 Dec;39(12):2381-6
references.pmid: 21940905
references.citation: Chirality. 2005 Mar;17(3):135-41
references.pmid: 15704197
references.citation: Arch Biochem Biophys. 1995 Jun 1;319(2):481-90
references.pmid: 7786031
references.citation: J Biol Chem. 2012 Nov 23;287(48):40690-702
references.pmid: 23019336
references.citation: Xenobiotica. 2001 Aug-Sep;31(8-9):677-86
references.pmid: 11569533
references.citation: Biochem J. 2003 May 15;372(Pt 1):15-32
references.pmid: 12578558
references.citation: J Med Chem. 2007 Sep 20;50(19):4642-7
references.pmid: 17718551
references.citation: Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):153-68
references.pmid: 23231678
references.citation: Eur J Drug Metab Pharmacokinet. 1987 Oct-Dec;12(4):307-10
references.pmid: 3130251
references.citation: Drug Metab Dispos. 2010 Feb;38(2):302-7
references.pmid: 19910515
references.citation: Drug Metab Pharmacokinet. 2006 Apr;21(2):83-98
references.pmid: 16702728
references.citation: Drug Metab Dispos. 2013 Jan;41(1):24-9
references.pmid: 22996261
references.citation: Drug Metab Dispos. 2012 Sep;40(9):1834-45
references.pmid: 22711749
references.citation: Drug Metab Dispos. 2004 Jan;32(1):89-97
references.pmid: 14709625
references.citation: Drug Metab Lett. 2008 Aug;2(3):176-83
references.pmid: 19356090
references.citation: Drug Metab Dispos. 2009 Dec;37(12):2393-8
references.pmid: 19741035
references.citation: Expert Opin Drug Discov. 2013 Jun;8(6):641-54
references.pmid: 23565746
references.citation: PLoS One. 2009;4(4):e5348
references.pmid: 19401776
references.citation: Mol Pharm. 2013 Apr 1;10(4):1262-8
references.pmid: 23363487
references.citation: Xenobiotica. 2013 May;43(5):399-408
references.pmid: 23046389
references.citation: Expert Opin Drug Metab Toxicol. 2012 Apr;8(4):487-503
references.pmid: 22335465
references.citation: Biochemistry. 2011 Dec 20;50(50):10804-18
references.pmid: 21992114
references.citation: Biochemistry. 1998 Jun 23;37(25):8848-52
references.pmid: 9636025
references.citation: Drug Metab Dispos. 1997 Jul;25(7):805-13
references.pmid: 9224775
references.citation: J Clin Psychopharmacol. 2003 Jun;23(3):229-32
references.pmid: 12826984
references.citation: J Clin Pharmacol. 2004 Jan;44(1):7-19
references.pmid: 14681337